Changes of Interleukin-10 level in Patients Undergoing cardiopulmonary Bypass

체외순환에 따른 혈중 Interleukin-10의 변화

  • 홍남기 (영남대학교 의과대학 흉부외과 교실) ;
  • 이동협 (영남대학교 의과대학 흉부외과 교실) ;
  • 정태은 (영남대학교 의과대학 흉부외과 교실) ;
  • 이정철 (영남대학교 의과대학 흉부외과 교실) ;
  • 한승세 (영남대학교 의과대학 흉부외과 교실)
  • Published : 2000.08.01

Abstract

Background: Cardiopulmonary bypass during open heart surgery causes systemic inflammatory respose. IL-10 is an anti-inflammatory cytokine that inhibits inflammatory process and protects organ function by down regulation of pro-inflammatory cytokine release and maintenance of blood level balance with pro-inflammatory cytokines. Mateial and Method: Plasma IL-10 levels were measured and analyzed in 22 patients who underwent open heart surgery (11 cases of coronary artery bypass graft, 11 cases of valve replacement) under cardiopulmonary bypass since 1988 January to July at Department of Thoracic and Czardiovascular surgery, Yeungnam University Hospital. 1g of methylprednisolone was administrated to thirteen patients randomly. Blood samp.es were taken and collected at the time of induction of anesthesia, 10 min before cardiopulmonary bypass, 10 min after starting of CPB, 10 min aftr aortic cross clamping, 10 min after ACC release, and 10 min, 2 hours, and `5 hours after CPB respectively. The plasma levels of IL-10 were determined by enzyme-linked immunosorbent assays(ELISA). Wilcoxon-Raule Sum test was used for statistical analysis. Result: In all 22 patients, cardiopulmonary bypass time was used for statistical analysis. Result: In all 22 patients, cardiopulmonary bypass time was 171$\pm$41.4 min and aortic cross clamp time was 118$\pm$36.5 min. Peak IL-10 level was achieved at 10 min after ACC(361.0$\pm$52.81pg/ml) and was decreased sharply at 2 hours after CPB. Peak IL-10 level was correlated positively with aortic cross clamp time(p=0.011); however, it did not correlated with bypass time(p=0.181). In valve replacement group, mean IL-10 level at peak point was 567.89$\pm$107.69 pg/ml and was significantly higher than that of coronary artery bypass group(205.67$\pm$192.70 pg/ml)(p<0.001). ACC time in valve replacement group was significantly longer than that of coronary artery bypass group(p<0.01), however, bypass time was not(p=0.212). Thirteen patients with steroid pretreatment before starting of CPB showed relatively higher plasma IL-10 level than in control group, however, no statistical significance was noted(p=0.19). Conclusion: plasma level of IL-10 was increased in association with cardiopulmonary bypass and revealed peak at 10 min after ACC release. IL-10 level was correlated positively with ACC time. Therefore, systemic inflammatory respeonse in association with cardiopulmonary bypass could be decreased by reducing ACC time during cardiac surgery.

Keywords

References

  1. Circulation v.92 Induction of interleukin-6 synthesis in the myocardium:potential role in post reperfusion inflammatory injury Kukiclka GL;Smith CW;Manning AM;Youker KA;Michael LH;Entman ML
  2. J Thorac Cardiovasc Surg v.98 Induction of inerleukin-1 production in patients undergoing cardiopulmonary bypass Haeffner-Cavaillon N;Roussellier N;Ponzio O
  3. Ann Rev Immunol v.8 Interleukin-6: an overview Van Snick J
  4. Ann Thorac Surg v.55 Inflammatory response to cardiopulmonary bypass Butler J;Rocker GM;Westaby S
  5. J Exp Med v.170 Two types of mouse helper T cell Ⅳ. Th2 clones secrete a factor that inhibits cytokine production y Th clones Fiorentino DF;Bond MW;Mosmann TR
  6. J Immunol v.61 Interleukin 10 protects mice against staphylococcal enterotoxin B- induced lethal shock Bean AGD;Reiberg RA
  7. J Immunol v.148 IL-10 inhibits T cell proliferation and IL-2 production Taga K;Tosato G
  8. Proc Natl Acad Sci USA v.88 Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones Viera P;Malefyt R;Dang MN(et al)
  9. Annu Rev Immunol v.11 Interleukin-10 Moorc KW;O'Gorra A;de Waal Malefyt R;Viera P;Mosmann TR
  10. J Exp Med v.174 Macrophage deactivation by IL-10 Bogdan, Vodovoz C;Nathan C
  11. J Immunol v.152 A role for nonspecific(cyclosporin A) or specific(monoclonal antibodies to ICAM-1,LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion Reginald M. Gorczynski;David wojeik
  12. Proc Natl Acad Sci v.89 Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes Rousset F;Garcia E;Defrance T(et al)
  13. Ann Thorac Surg v.63 Cytokine responses to cardiopulmonary bypass:Lessons Learned from cardiac transplantation Wan S;LeClerc JL;Vincent JL
  14. Hepatology v.20 Systemic release of interleukin-10 during orthotopic liver transplantation Le Moine O;Marchant A;Durand F(et al)
  15. Can J Anaesth v.44 Interleukin-10 and interleukin-1 receptor antagonists increase antagonists increase during cardiac surgery Kawamura T;Wakusawa R;Inada K
  16. Ann Thorac Surg v.65 Aprotinm enhances the endogenous release of interleukin-10 after cardiac operations Hill GE;Diego RP;Stammers Ah;Huffman SM;Pohorecki R
  17. J Thorac Cardiovasc Surg v.110 Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans Hill GE;Alonso A;Spurzern JR;Stammers AH;Robbins RA
  18. J Thorac Cardiovasc Surg v.81 Complement activation and neutropenia occurring during cardiopulmonary bypass hammerschmidt K;Stroncek DF;Bowers TK(et al)
  19. J Thorac Cardiovasc Surg v.102 Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass Jansen NJG;Van Oeveren W;Broek LVD(et al)
  20. Surgery v.119 Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men Tabardel Y;Duchateau J;Schmartz D(et al)
  21. J Cariothorac Anesth v.3 Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery Anderson LW;Baek L;Thomsen BS